Rocket Lab posts a record $268 million quarter and $3.6 billion backlog, but the loss widens to $79.7 million

Rocket Lab reported third-quarter revenue of $267.8 million on Monday, up 73% from $155.1 million a year earlier, and said its backlog reached about $3.57 billion. The figures are in the company's results release, filed with the SEC. According to Investing.com, analysts had expected revenue of about $257 million and a loss of $0.07 a share. The reported loss was $0.12.

The stock rose 10.9% in regular trading to close at $58.86, according to Nasdaq.com, then traded at $55.06 (-6.5%) at 6:41 PM ET. After-hours prices are thin and can change quickly.

The numbers

Margins are our arithmetic from the release's income statement. Revenue grew faster than gross profit, so the share of each sales dollar left after production costs fell by about 3.4 points on a GAAP basis and 3.5 points on the company's non-GAAP basis. Operating expenses rose 46% to $169.3 million.

Why the net loss looks so much worse

The headline jump in net loss, from $18.3 million to $79.7 million, overstates the deterioration. Last year's quarter included a $41.1 million income tax benefit. Before taxes, the loss widened from $59.3 million to $76.2 million, or $16.8 million. This year's quarter also carried a $27.3 million loss on extinguishing debt and $21.3 million of transaction costs, up from $5.1 million a year ago. The release does not itemize the transaction costs, but the company is mid-way through buying Iridium Communications. On the adjusted measure the company prefers, the loss narrowed: adjusted EBITDA was -$18.0 million against -$26.3 million.

That is the useful way to read the "miss": it is partly one-time deal and financing cost, partly a thinner gross margin as the mix shifts toward spacecraft. Investing.com reported that Space Systems made up about $214.8 million of sales, roughly 80%, and Launch Services about $53.1 million.

The number behind the number: $3.9 billion of new stock

The cash flow statement shows what is funding all this. In the first nine months Rocket Lab raised $3.91 billion through at-the-market equity offerings, and cash and equivalents stand at $4.45 billion, up from $829 million at the end of 2025. Common shares outstanding rose from 543.6 million to 639.2 million over the nine months, about 17.6% more shares. The company says that equity offering fully funds the Iridium purchase.

Interest income on that pile was $28.6 million in the quarter, more than the entire $18.0 million adjusted EBITDA loss, and the company guides to $45 million of net interest income in Q4. Operating cash flow turned positive in Q3 at $7.2 million, but for nine months it is still negative $127.3 million, with $84.2 million spent on equipment and software. Anyone comparing per-share results should keep in mind that the share count is rising: the company guides to 681 million weighted shares in Q4, including about 41 million preferred shares.

Backlog and Neutron

Backlog grew by $1.2 billion, or 52%, since the end of the second quarter. The company says nearly $1 billion came from new launch contracts across Electron, HASTE and Neutron, and $470 million from Space Systems. It signed more than $515 million of Neutron launch contracts in the quarter, taking that rocket to 16 contracted missions before its first flight. Some of those contracts carry a base price of $70 million, which the company links to tightening industry launch capacity. First launch is targeted for no earlier than 2027, so none of that Neutron revenue arrives in the near term.

For satellite operators and defense contractors, the pricing is the signal. A rocket company that can lift its base price while customers still sign is telling the market that launch seats are scarce. The flip side for builders of constellations is that scarcity raises their own costs.

Guidance for Q4

• Revenue of $270 million to $290 million, against $267.8 million in Q3, so growth of roughly 1% to 8% from the quarter just reported.
• Non-GAAP gross margin of 39% to 41% (38.4% in Q3); GAAP gross margin of 34% to 36%.
• Adjusted EBITDA loss of $14 million to $20 million, against $18.0 million in Q3.

The sequential growth guided for Q4 is slower than the 14.4% reported for Q3, which is one reason a record quarter did not hold the stock's gains after the close.

What was behind Monday's gain

The regular-session jump came before the results. Investor's Business Daily and Yahoo Finance headlined that space stocks rose after NASA handed out about $10 billion in moon base awards; our own report on that is here. The after-hours drop is therefore a reaction to the loss and the growth outlook as much as to the quarter itself.

Nasdaq.com lists a 52-week range of $37.57 to $150.9999 and a market value of about $36.9 billion. Even after Monday's rise the shares remain well below their May peak, as our chart shows. We will update this story if the earnings call or the 10-Q change any of these figures.

Sources: Rocket Lab Q3 2026 results (SEC EDGAR, Form 8-K Exhibit 99.1); Rocket Lab filings on SEC EDGAR; Nasdaq.com quotes; Investing.com. Some data may be delayed. This is market information, not investment advice.